Characteristics of GALLIVAC Se
With several years of proven results in Europe, GALLIVAC Se has established a
reputation for reliability and safety. Developed by IDT in Germany, a vaccine laboratory with world
renowned expertise in Salmonella control, GALLIVAC Se is a highly immunogenic homologous live
Salmonella enteritidis vaccine developed to meet your needs.
Features & Benefits of GALLIVAC Se
- Registered as two-dose regimen.
- Licenced for drinking water administration.
- Homologous strain Salmonella enteritidis vaccine stimulating the
most appropriate immune response.
- Stimulates comprehensive active and passive immune response; 'inhibition phenomenon', local, cell mediated and humoral/circulating immunity.
- Onset of active immunity 6 days post the first vaccination.
- No interference by maternally derived antibody to S.e.
- Double attenuated, genetically stable & avirulent.
- Easily distinguishable from field strains by means of a rapid, specific diagnostic test.
- No cross reacting antibodies to the S. gallinarum test are generated.
